Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Depreciation & Amortization - Total (2016 - 2017)

Nutex Health's Depreciation & Amortization - Total history spans 5 years, with the latest figure at $213.0 for Q1 2017.

  • For Q1 2017, Depreciation & Amortization - Total rose 80.51% year-over-year to $213.0; the TTM value through Dec 2017 reached $213.0, down 54.97%, while the annual FY2016 figure was $473.0, 28.55% down from the prior year.
  • Depreciation & Amortization - Total for Q1 2017 was $213.0 at Nutex Health, up from -$16723.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $12505.0 in Q2 2016 and bottomed at -$16723.0 in Q4 2016.
  • The 5-year median for Depreciation & Amortization - Total is $1191.0 (2014), against an average of $534.0.
  • The largest YoY upside for Depreciation & Amortization - Total was 2671.52% in 2016 against a maximum downside of 10174.1% in 2016.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $1673.0 in 2013, then decreased by 28.75% to $1192.0 in 2014, then crashed by 86.07% to $166.0 in 2015, then crashed by 10174.1% to -$16723.0 in 2016, then soared by 101.27% to $213.0 in 2017.
  • Per Business Quant, the three most recent readings for NUTX's Depreciation & Amortization - Total are $213.0 (Q1 2017), -$16723.0 (Q4 2016), and $4573.0 (Q3 2016).